APP
GRTS

Avantax Planning Partners’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Avantax Planning Partners’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17,858
Closed -$11K – 492
2024
Q2 		$11K Hold
17,858
– – ﹤0.01% 470
2024
Q1 		$45.9K Buy
+17,858
New +$43.6K ﹤0.01% 458

Other funds holding GRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Avantax Planning Partners's GRTS Position: Q3 2024 in Review

Avantax Planning Partners sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 17,858 shares — an estimated $11K sold.

Avantax Planning Partners first reported a position in GRTS in Q1 2024 and held it in 2 quarters. The position peaked at $45.9K in Q1 2024. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • Avantax Planning Partners reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Avantax Planning Partners sold 17,858 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $11K.
  • Avantax Planning Partners first reported a position in Gritstone bio, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Avantax Planning Partners's Gritstone bio, Inc. Common Stock position peaked at $45.9K in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Avantax Planning Partners's 13F filing for Q3 2024, filed 14 Nov 2024.